Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Hybrid foot‑pedal exoskeleton gait therapy with adjustable active assistance for people after chronic stroke

Official title: The Feasibility and Therapeutic Effect of Hybrid End-effector Robot-assisted Gait Training With an Active-assisted Module in Chronic Stroke Survivors

Run by National Taiwan University Hospital · NCT07034521 · Data updated 2026-11-12

This test tries a new foot‑pedal exoskeleton (HIWIN MRG‑P110) with adjustable active assistance to see if it helps people 6 months to 3 years after a first stroke walk better.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei, Taipei)
StatusRecruiting
StartedAugust 12, 2025
Main results expectedDecember 31, 2027
Study endsMay 2028
Registry record updatedMay 19, 2026
Trial IDNCT07034521 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–80 who had a first stroke 6 months to 3 years ago, were independent walkers before the stroke, and currently have limited walking ability (FAC 0–3) but fit the device size and weight limits.

Probably not a fit

People with severe lower‑limb contractures or spasticity (Modified Ashworth Scale 4), significant musculoskeletal pain or wounds, severe osteoporosis or prior hip/spine fracture, or body size outside device limits are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional feasibility study uses the HIWIN MRG‑P110 end‑effector exoskeleton, which drives hip and knee movement via foot pedals and lets clinicians adjust how much active assistance the device provides. Adults 18–80 with a first-ever stroke 6 months to 3 years earlier and limited walking ability (FAC 0–3) will use the device for supervised gait training. The protocol focuses on usability measures and therapeutic outcomes such as gait and motor function changes while monitoring safety and tolerability. Participants who cannot fit the device or who have severe musculoskeletal or bone conditions are excluded.

Why it matters

Potential benefit: If successful, the device could improve walking ability and increase voluntary engagement in gait training for some people living with chronic stroke.

How similar studies have gone: Previous robot‑assisted gait studies have shown modest to meaningful walking gains for some stroke patients, but this specific end‑effector device with an adjustable active‑assist module is relatively new and less studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged between 18 and 80 years old.
* First-ever stroke, confirmed by brain CT or MRI, with onset between 6 months and 3 years prior to enrollment.
* Walking ability classified as Functional Ambulation Category (FAC) level 1 to level 3.
* Prior to the current stroke, the participant was an independent community ambulator without mobility impairments.

Exclusion Criteria:

* Presence of lower limb joint contractures, deformities, or severe spasticity (Modified Ashworth Scale score of 4).
* Lower limb musculoskeletal conditions causing wounds, pain, inability to bear weight, or significant leg length discrepancy (\>2 cm after orthotic correction).
* Known history of osteoporotic fractures in the thoracolumbar spine or hip joints.
* Inability to use the exoskeleton device due to body size, including:

Body weight \> 135 kg; Thigh length \< 36 cm or \> 48 cm; Calf length \< 42 cm or \> 58 cm

* Cognitive or communication impairments that prevent understanding of study instructions or completion of questionnaires.
* Acute infections or unstable vital signs.
* Significant orthostatic hypotension or inability to maintain upright posture for more than 30 minutes.
* Use of indwelling urinary catheter or tracheostomy.
* Pregnant women.
* Terminal illness with life expectancy less than six months.
* Inability to attend 15 rehabilitation sessions and follow-up assessment at 3 months.

Where it's running

  • National Taiwan University Hospital
    Taipei, Taipei, Taiwan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.